About Carlina Technologies
Carlina Technologies is a company based in Angers (France) founded in 2010. Carlina Technologies has raised $398.75 thousand across 1 funding round from investors including GO CAPITAL. Carlina Technologies operates in a competitive market with competitors including PharmaJet, Arecor, Suono Bio, Renovis and Ensysce, among others.
- Headquarter Angers, France
- SectorsTechnologyHealthcare
- Website carlinatech.com
- Social LinkedIn X Facebook
- Total Equity Funding$398.75K (USD)
in 1 rounds
- Latest Funding Round$398.75K (USD), Seed
Jun 2012
- Investors
Funding Insights of Carlina Technologies
Carlina Technologies has successfully raised a total of $398.75K through 1 strategic funding round. The most recent funding activity was a Seed round of $398.75 thousand completed in June 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $398,750
- Total Rounds 1
- Last Round Seed — $398,750
- First Round $398,750
(Jun 2012)
- Investors Count 1
All 1 funding rounds of Carlina Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2012 | $398,750 | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Carlina Technologies
Carlina Technologies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include GO CAPITAL.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward multiple sectors. | 2003 | gocapital.fr | Rennes, France |
Investor details for Carlina Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Carlina Technologies
2 dated milestones of Carlina Technologies across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Carlina Technologies is founded.
- Funding First funding round of $399K.
Competitors of Carlina Technologies
Carlina Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PharmaJet, Arecor, Suono Bio, Renovis and Ensysce, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pharmajet.com | 2005 | Golden, United States | $59.4M | 15 | Provider of needle-free injection technology | |
| arecor.com | 2007 | Cambridge, United Kingdom | $8M | 34 | Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery | |
| suonobio.com | 2015 | Cambridge, United States | $12.68M | – | Developer of technology to enable ultra-rapid delivery of therapeutics to the gastrointestinal tract | |
| renovis.com | 2000 | San Francisco, United States | $45M | 368 | Drugs for neurological diseases are discovered and developed. | |
| ensysce.com | 2008 | Houston, United States | $2.5M | – | Drug delivery solutions via single-walled carbon nanotubes are offered. | |
| splice.bio | 2020 | Barcelona, Spain | $191.7M | – | Provider of a proprietary platform for gene therapy | |
| erydel.com | 2007 | Milan, Italy | $31.7M | – | Erythrocyte encapsulation systems for drug delivery are developed. | |
| vsparticle.com | 2014 | Delft, Netherlands | $22.91M | – | Nanopowder manufacturing services and nanoparticle generators are provided. | |
| oxsonics.com | 2013 | Oxford, United Kingdom | $15.94M | 14 | Developer of ultrasound technologies to enhance anticancer drug delivery to solid tumors | |
| oxular.com | 2014 | Oxford, United Kingdom | $57.53M | 6 | Drug delivery platforms and therapeutics for ophthalmology are developed. |
Detailed competitors of Carlina Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Carlina Technologies
Complete news archive for Carlina Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Carlina Technologies
10 companies that operate in the same segment as Carlina Technologies (Nanotechnology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 | |
Nanotech-based electrode materials for supercapacitors are provided. | 2009 | Boston, Massachusetts, United States | USD 163.32 M | – | 66 | |
Instrument systems and software for single-molecule real-time sequencing are developed. | 2004 | Menlo Park, California, United States | USD 395 M | USD 160 M | 575 | |
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | – | – | |
RNA therapeutics for hematology and cardiovascular diseases are developed. | 1999 | London, England, United Kingdom | – | USD 559 K | 116 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Carlina Technologies
Carlina Technologies was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Carlina Technologies is headquartered in Angers, France. It is registered at Angers, Pays De La Loire, France.
Carlina Technologies is a funded company, having raised a total of $398.75K across 1 funding round to date. The company's 1st funding round was a Seed of $398.75K, raised on Jun 2012.
Carlina Technologies is engaged in the development of nanomedicines utilizing innovative non-denaturing drug delivery technologies for therapeutic proteins, peptides and other typesof drugs.The company develops controlled-release pharmaceutical versions of drugs capable of targeting them to their site of action. This results in increased efficacy and safety of treatments leading to improved patients compliance and quality of life. Research services offered include pre-formulation, formulation, process manufacturing, preclinical batch production, stability studies, analytical method development, and scale-up and technology transfer. Its proprietary drug delivery systems include peptidots, soludots, liposomes, micelles, microspheres, nano-emulsions, and hydrogels. The pipeline includes peptidots-insulin for diabetes in preclinical stage and peptidots-somatotropin for growth hormone deficiency in lead optimization stage.
Carlina Technologies's top competitors include Oxular, PharmaJet and Splice Bio.
Carlina Technologies has 1 investor. Key investors include GO CAPITAL.